Annual report
6036.TEDINET S100UG2L
Period2023-07-01 → 2024-06-30
Filed2024-09-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.6bn | 2023-07-01 → 2024-06-30 | Standalone | Net sales |
| Revenue | ¥17.0bn | 2022-07-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥14.4bn | 2021-07-01 → 2022-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥11.8bn | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.7bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥6.1bn | 2023-07-01 → 2024-06-30 | Standalone | Operating income |
| Operating income | ¥5.5bn | 2022-07-01 → 2023-06-30 | Standalone | Operating income |
| Ordinary income | ¥6.1bn | 2023-07-01 → 2024-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥5.5bn | 2022-07-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥4.3bn | 2021-07-01 → 2022-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.0bn | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.1bn | 2023-07-01 → 2024-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥5.5bn | 2022-07-01 → 2023-06-30 | Standalone | Income before income taxes |
| Net income | ¥4.4bn | 2023-07-01 → 2024-06-30 | Standalone | Profit loss |
| Net income | ¥4.0bn | 2022-07-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | ¥3.1bn | 2021-07-01 → 2022-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.1bn | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥913m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥19.3bn | at 2024-06-30 | Standalone | Assets |
| Total assets | ¥15.1bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥11.9bn | at 2022-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.2bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.6bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2024-06-30 | Standalone | Liabilities |
| Total liabilities | ¥3.9bn | at 2023-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥14.5bn | at 2024-06-30 | Standalone | Net assets |
| Net assets / equity | ¥11.2bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥8.0bn | at 2022-06-30d | Standalone | Net assets |
| Net assets / equity | ¥5.6bn | at 2021-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥5.8bn | at 2020-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.1bn | at 2024-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.6bn | at 2023-06-30 | Standalone | Cash and deposits |
| Cash & equivalents | ¥5.1bn | at 2024-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥3.6bn | at 2023-06-30 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.7bn | at 2022-06-30d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2021-06-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.9bn | at 2020-06-30d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.3bn | 2023-07-01 → 2024-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2022-07-01 → 2023-06-30 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.2bn | 2021-07-01 → 2022-06-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.1bn | 2020-07-01 → 2021-06-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2019-07-01 → 2020-06-30d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.5bn | 2023-07-01 → 2024-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.6bn | 2022-07-01 → 2023-06-30 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.3bn | 2021-07-01 → 2022-06-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥740m | 2020-07-01 → 2021-06-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2019-07-01 → 2020-06-30d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2023-07-01 → 2024-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2022-07-01 → 2023-06-30 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥669m | 2021-07-01 → 2022-06-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.7bn | 2020-07-01 → 2021-06-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥213m | 2019-07-01 → 2020-06-30d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥162.02 | 2023-07-01 → 2024-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥145.06 | 2022-07-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥113.41 | 2021-07-01 → 2022-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.65 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.31 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥32.29 | 2019-07-01 → 2020-06-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2023-07-01 → 2024-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2022-07-01 → 2023-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥31 | 2021-07-01 → 2022-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥530.08 | at 2024-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥408.77 | at 2023-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥294.71 | at 2022-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥204.05 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥206.25 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 75.0% | at 2024-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.9% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2022-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.6% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.2% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 34.5% | 2023-07-01 → 2024-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 41.2% | 2022-07-01 → 2023-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 45.5% | 2021-07-01 → 2022-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 37.4% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 28,280,840 | at 2024-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,280,840 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,280,840 | at 2022-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 28,280,840 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 14,140,420 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,041 | at 2024-06-30 | Standalone | Number of employees |
| Employees | 959 | at 2023-06-30 | Standalone | Number of employees |
| Employees | 727 | at 2022-06-30d | Standalone | Number of employees |
| Employees | 644 | at 2021-06-30d | Standalone | Number of employees |
| Employees | 490 | at 2020-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 50
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-07-01 → 2024-06-30 | ¥74m |
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-06-30 | −¥386m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-06-30 | −¥386m |
| Reconciling Itemsreconciling | segment assets | at 2024-06-30 | ¥6.8bn |
| Kee Per LABO Operationreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥3.7bn |
| Kee Per LABO Operationreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥379m |
| Kee Per LABO Operationreportable segment | employees | at 2024-06-30 | 902 pure |
| Kee Per LABO Operationreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥11.2bn |
| Kee Per LABO Operationreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥11.2bn |
| Kee Per LABO Operationreportable segment | segment assets | at 2024-06-30 | ¥9.0bn |
| Kee Per LABO Operationreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥2.3bn |
| Kee Per Products And Others Relatedreportable segment | capex | 2023-07-01 → 2024-06-30 | ¥71m |
| Kee Per Products And Others Relatedreportable segment | depreciation | 2023-07-01 → 2024-06-30 | ¥68m |
| Kee Per Products And Others Relatedreportable segment | employees | at 2024-06-30 | 98 pure |
| Kee Per Products And Others Relatedreportable segment | revenue | 2023-07-01 → 2024-06-30 | ¥9.8bn |
| Kee Per Products And Others Relatedreportable segment | revenue external | 2023-07-01 → 2024-06-30 | ¥9.4bn |
| Kee Per Products And Others Relatedreportable segment | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥386m |
| Kee Per Products And Others Relatedreportable segment | segment assets | at 2024-06-30 | ¥3.5bn |
| Kee Per Products And Others Relatedreportable segment | segment profit | 2023-07-01 → 2024-06-30 | ¥3.8bn |
| —segment total | capex | 2023-07-01 → 2024-06-30 | ¥3.8bn |
| —segment total | depreciation | 2023-07-01 → 2024-06-30 | ¥447m |
| —segment total | revenue | 2023-07-01 → 2024-06-30 | ¥21.0bn |
| —segment total | revenue external | 2023-07-01 → 2024-06-30 | ¥20.6bn |
| —segment total | revenue intersegment | 2023-07-01 → 2024-06-30 | ¥386m |
| —segment total | segment assets | at 2024-06-30 | ¥12.5bn |
| —segment total | segment profit | 2023-07-01 → 2024-06-30 | ¥6.1bn |
| Reconciling Itemsreconciling | capex | 2022-07-01 → 2023-06-30 | ¥113m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-06-30 | −¥318m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-06-30 | −¥318m |
| Reconciling Itemsreconciling | segment assets | at 2023-06-30 | ¥4.9bn |
| Kee Per LABO Operationreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥1.4bn |
| Kee Per LABO Operationreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥281m |
| Kee Per LABO Operationreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥9.7bn |
| Kee Per LABO Operationreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥9.7bn |
| Kee Per LABO Operationreportable segment | segment assets | at 2023-06-30 | ¥7.1bn |
| Kee Per LABO Operationreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥2.6bn |
| Kee Per Products And Others Relatedreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥15m |
| Kee Per Products And Others Relatedreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥50m |
| Kee Per Products And Others Relatedreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥7.7bn |
| Kee Per Products And Others Relatedreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥7.4bn |
| Kee Per Products And Others Relatedreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥318m |
| Kee Per Products And Others Relatedreportable segment | segment assets | at 2023-06-30 | ¥3.0bn |
| Kee Per Products And Others Relatedreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥2.8bn |
| —segment total | capex | 2022-07-01 → 2023-06-30 | ¥1.4bn |
| —segment total | depreciation | 2022-07-01 → 2023-06-30 | ¥331m |
| —segment total | revenue | 2022-07-01 → 2023-06-30 | ¥17.4bn |
| —segment total | revenue external | 2022-07-01 → 2023-06-30 | ¥17.0bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥318m |
| —segment total | segment assets | at 2023-06-30 | ¥10.1bn |
| —segment total | segment profit | 2022-07-01 → 2023-06-30 | ¥5.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,069
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 5797600 | |
| Shareholding ratio | CurrentYearInstant_No1MajorShareholdersMember | 0.2124 | |
| Number of shares held | CurrentYearInstant_No2MajorShareholdersMember | 4657600 | |
| Shareholding ratio | CurrentYearInstant_No2MajorShareholdersMember | 0.1706 | |
| Number of shares held | CurrentYearInstant_No3MajorShareholdersMember | 2516200 | |
| Shareholding ratio | CurrentYearInstant_No3MajorShareholdersMember | 0.0921 | |
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 1280000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0469 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 1178000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0431 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 970700 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0356 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 832000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0305 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 646600 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0237 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 636600 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0233 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 432000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0158 | |
| Number of shares held | CurrentYearInstant_No11MajorShareholdersMember | 432000 | |
| Shareholding ratio | CurrentYearInstant_No11MajorShareholdersMember | 0.0158 | |
| Number of shares held | CurrentYearInstant | 19379300 | |
| Shareholding ratio | CurrentYearInstant | 0.7098 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 989000 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 272663 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 27266300 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 25540 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 28280840 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 272663 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 989000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 989000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0350 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 989000 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 989000 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0350 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 1364590000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 50.00 | |
| Number of male directors and other officers | FilingDateInstant | 10 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.166 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E31216-000TaniYoshimichiMember | 40000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E31216-000KakuToshiyukiMember | 1178000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E31216-000SuzuokiChikashiMember | 644400 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |